Phanes Therapeutics Secures FDA Orphan Drug Designation for PT217 in Treating Neuroendocrine Carcinoma

Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today th...

August 19, 2024 | Monday | News
Parexel’s Greenhouse Gas Reduction Targets Earn SBTi Validation, Marking Key Milestone in Net-Zero Commitment

Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...

August 13, 2024 | Tuesday | News
Shanghai Junshi Biosciences’ Toripalimab sNDA Accepted by NMPA for First-Line Treatment of Advanced Melanoma

Shanghai Junshi Biosciences Co., a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of ...

August 13, 2024 | Tuesday | News
Merck Life Science India and Aragen Life Sciences Sign Landmark MoU to Accelerate mAb Manufacturing and Innovation

Merck Life Science in India  announced the signing of a Memorandum of Understanding (MoU) with Aragen Life Sciences, a leading provider of R&D a...

August 09, 2024 | Friday | News
Vertex Pharmaceuticals Secures Landmark Reimbursement Deal with NHS England for First CRISPR Gene-Edited Therapy

Vertex Pharmaceuticals (Nasdaq: VRTX) announced  a reimbursement agreement with NHS England for eligible transfusion-dependent beta thalassemia (TDT...

August 09, 2024 | Friday | News
Parse Biosciences Partners with Prisma Biotech to Expand Single-Cell Sequencing Reach in Asia-Pacific

-Parse Biosciences, a leading provider of cost-effective and scalable solutions for single-cell sequencing, today announced an agreement with the Taiwane...

August 08, 2024 | Thursday | News
PacBio's HiFi Sequencing Technology Chosen for Singapore's Largest Long-Read Sequencing Project

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced that Precision Health Research, Singapore (PR...

August 06, 2024 | Tuesday | News
NurExone Biologic Inc Achieves GMP-Grade Manufacturing for ExoPTEN Nanodrug’s siRNA Sequence

NurExone Biologic Inc, a pioneering biopharmaceutical company, is thrilled to announce an important milestone in its regenerative medicine efforts. The C...

August 02, 2024 | Friday | News
AbCellera Expands Collaboration with Eli Lilly to Develop Therapeutic Antibodies Across Multiple Therapeutic Areas

AbCellera (Nasdaq: ABCL) announcedthat it has expanded its existing collaboration with Eli Lilly and Company (Lilly) to discover therapeutic antibodies f...

August 01, 2024 | Thursday | News
Novo Holdings Invests £50M in Oxford Nanopore Technologies, Pioneers of Advanced DNA/RNA Sequencing

Investment in Oxford Nanopore, innovators of a transformational new generation of sensing technology that today specialises in DNA/RNA sequencing &pou...

August 01, 2024 | Thursday | News
Biogen, Beckman Coulter, and Fujirebio Announce Collaboration to Develop Blood Biomarkers for Alzheimer's Disease

The collaboration aims to identify and develop accessible and mini-invasive blood biomarkers specific to tau pathology in the brain These tools ...

July 31, 2024 | Wednesday | News
IDT Pioneers CRISPR Safety and Accuracy with Advanced Technologies

  In a recent Q&A session with BioPharma BoardRoom, Gavin Kurgan, Bioinformatics Applications Development Manager at Integrated DNA Technologies ...

July 29, 2024 | Monday | Interaction
Nexcella Secures $8 Million CIRM Grant to Advance CAR-T Therapy for AL Amyloidosis

Nexcella, Inc.  a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and autoimmune disease, today announced tha...

July 26, 2024 | Friday | News
Oxford Nanopore and Plasmidsaurus Announce Multi-Year Partnership to Transform Plasmid Sequencing

Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, and Plasmidsaurus, the LA-based com...

July 25, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close